164 related articles for article (PubMed ID: 35583280)
1. [Does high-dose intravenous vitamin C has anti-cancer activity ?].
Courtes MG; Baudoux N; Astaras C; Fernandez E
Rev Med Suisse; 2022 May; 18(782):1002-1006. PubMed ID: 35583280
[TBL] [Abstract][Full Text] [Related]
2. Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later?
Cabanillas F
P R Health Sci J; 2010 Sep; 29(3):215-7. PubMed ID: 20799507
[TBL] [Abstract][Full Text] [Related]
3. Intravenously administered vitamin C as cancer therapy: three cases.
Padayatty SJ; Riordan HD; Hewitt SM; Katz A; Hoffer LJ; Levine M
CMAJ; 2006 Mar; 174(7):937-42. PubMed ID: 16567755
[TBL] [Abstract][Full Text] [Related]
4. Targeting cancer vulnerabilities with high-dose vitamin C.
Ngo B; Van Riper JM; Cantley LC; Yun J
Nat Rev Cancer; 2019 May; 19(5):271-282. PubMed ID: 30967651
[TBL] [Abstract][Full Text] [Related]
5. The potential role of vitamin C in empowering cancer immunotherapy.
Bedhiafi T; Inchakalody VP; Fernandes Q; Mestiri S; Billa N; Uddin S; Merhi M; Dermime S
Biomed Pharmacother; 2022 Feb; 146():112553. PubMed ID: 34923342
[TBL] [Abstract][Full Text] [Related]
6. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer.
Böttger F; Vallés-Martí A; Cahn L; Jimenez CR
J Exp Clin Cancer Res; 2021 Oct; 40(1):343. PubMed ID: 34717701
[TBL] [Abstract][Full Text] [Related]
7. Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability, and DNA synthesis.
Maramag C; Menon M; Balaji KC; Reddy PG; Laxmanan S
Prostate; 1997 Aug; 32(3):188-95. PubMed ID: 9254898
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C pharmacokinetics: implications for oral and intravenous use.
Padayatty SJ; Sun H; Wang Y; Riordan HD; Hewitt SM; Katz A; Wesley RA; Levine M
Ann Intern Med; 2004 Apr; 140(7):533-7. PubMed ID: 15068981
[TBL] [Abstract][Full Text] [Related]
9. The Result of Vitamin C Treatment of Patients with Cancer: Conditions Influencing the Effectiveness.
Hunyady J
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457200
[TBL] [Abstract][Full Text] [Related]
10. Why Vitamin C Could Be an Excellent Complementary Remedy to Conventional Therapies for Breast Cancer.
Codini M
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182353
[TBL] [Abstract][Full Text] [Related]
11. High-Dose Vitamin C in Advanced-Stage Cancer Patients.
Zasowska-Nowak A; Nowak PJ; Ciałkowska-Rysz A
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652579
[TBL] [Abstract][Full Text] [Related]
12. [Vitamin C and Cancer, friends or foes?].
Mardones L
Rev Med Chil; 2020 Jul; 148(7):1047-1048. PubMed ID: 33399694
[No Abstract] [Full Text] [Related]
13. Review of high-dose intravenous vitamin C as an anticancer agent.
Wilson MK; Baguley BC; Wall C; Jameson MB; Findlay MP
Asia Pac J Clin Oncol; 2014 Mar; 10(1):22-37. PubMed ID: 24571058
[TBL] [Abstract][Full Text] [Related]
14. Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells.
Lee SJ; Jeong JH; Lee IH; Lee J; Jung JH; Park HY; Lee DH; Chae YS
Anticancer Res; 2019 Feb; 39(2):751-758. PubMed ID: 30711954
[TBL] [Abstract][Full Text] [Related]
15. Vitamin C as a cancer treatment: state of the science and recommendations for research.
Tamayo C; Richardson MA
Altern Ther Health Med; 2003; 9(3):94-101. PubMed ID: 12776480
[No Abstract] [Full Text] [Related]
16. The Emerging Role of Vitamin C as a Treatment for Sepsis.
Kashiouris MG; L'Heureux M; Cable CA; Fisher BJ; Leichtle SW; Fowler AA
Nutrients; 2020 Jan; 12(2):. PubMed ID: 31978969
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulation.
Mastrangelo D; Pelosi E; Castelli G; Lo-Coco F; Testa U
Blood Cells Mol Dis; 2018 Mar; 69():57-64. PubMed ID: 28954710
[TBL] [Abstract][Full Text] [Related]
18. Retinol palmitate and ascorbic acid: Role in oncological prevention and therapy.
de Carvalho Melo-Cavalcante AA; da Rocha Sousa L; Alencar MVOB; de Oliveira Santos JV; da Mata AMO; Paz MFCJ; de Carvalho RM; Nunes NMF; Islam MT; Mendes AN; Gonçalves JCR; da Silva FCC; Ferreira PMP; de Castro E Sousaa JM
Biomed Pharmacother; 2019 Jan; 109():1394-1405. PubMed ID: 30551390
[TBL] [Abstract][Full Text] [Related]
19. Vitamin C at high concentrations induces cytotoxicity in malignant melanoma but promotes tumor growth at low concentrations.
Yang G; Yan Y; Ma Y; Yang Y
Mol Carcinog; 2017 Aug; 56(8):1965-1976. PubMed ID: 28370562
[TBL] [Abstract][Full Text] [Related]
20. Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress.
Klingelhoeffer C; Kämmerer U; Koospal M; Mühling B; Schneider M; Kapp M; Kübler A; Germer CT; Otto C
BMC Complement Altern Med; 2012 May; 12():61. PubMed ID: 22551313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
